SK Bioscience Co. on Thursday reported its fourth-quarter net income of 4.2 billion won (US$3.1 million), down 85 percent from a year earlier. The company said in a regulatory filing that it posted an operating loss of 8.4 billion won for the October-December period, compared with a profit of 8.7 billion won a year ago. Revenue fell 35.4 percent to 90.6 billion won. (END) Source: Yonhap News Agency